Table 1. Baseline characteristics of 110 patients with NBD and 98 patients with parenchymal NBD.
Data are n (%), mean±SD, or median [interquartile range] values.
*Pathergy test was conducted in 31 of all NBD patients and 29 of parenchymal NBD patients, †HLA-B51 test was conducted in 48 of all NBD patients and 41 of parenchymal NBD patients, ‡CSF analysis was performed in 64 of all NBD patients and 56 of parenchymal NBD patients.
BD: Behçet's disease, CSF: cerebrospinal fluid, NBD: neuro-Behçet's disease.